Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelodysplastic syndromes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia
• Chronic Myeloid Leukemia
• Megakaryoblastic Leukemia
• Monocytic Leukemia
• Myelodysplastic Syndromes
• Undifferentiated Leukemia

Drugs mentioned

• SB-715992

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) | Phase 1 | Status: COMPLETED